Summary:
The purpose of this study is to compare a FDA approved single therapy inhaler that combines 3 COPD medications to Spiriva for patient convenience.
This study is about 3 months long and will consist of 6 office visits. All visits are conducted locally in Salt Lake City, Utah.
Qualified Participants Must:
• Be at least 40 years old
•
Be diagnosed with COPD
•
Be taking Spiriva consistently for 3 months
Qualified Participants May Receive:
- Receive $125 per completed visit, starting after your 2nd visit.
- Study medications provided.
- No cost to participate.
- No insurance needed.
- No change in your doctor.
- Completely voluntary, no obligation to continue.